Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.5750 (-1.35%) ($10.5750 - $10.5750) on Fri. Feb. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 59 | Latest Price | $10.5750(-1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(31%) IBB(28%) SDY(27%) XLRE(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.735% in a week (0% probabilities). VIXM(-16%) UUP(-10%) VXX(-7%) TBT(-1%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.53(0.43%) | 10 Day Moving Average | $10.64(-0.61%) | 20 Day Moving Average | $10.53(0.43%) | To recent high | -23.3% | To recent low | 5.8% | Market Cap | $1.866b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |